Related Experiment Video
Updated: Dec 5, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
Kazuhito Kawata1, Satoru Joshita2, Shinji Shimoda3
1Department of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
The ursodeoxycholic acid response score (URS) predicts biochemical response in primary biliary cholangitis (PBC) patients. It also correlates with liver histology, aiding in assessing treatment effectiveness.
Area of Science:
- Hepatology
- Gastroenterology
- Biochemistry
Background:
- Primary biliary cholangitis (PBC) is a chronic liver disease.
- Ursodeoxycholic acid (UDCA) is a primary treatment for PBC.
- Predicting treatment response is crucial for managing PBC.
Purpose of the Study:
- To evaluate the ursodeoxycholic acid response score (URS) for predicting biochemical response to UDCA in PBC.
- To investigate the association between the URS and histopathological features before and after UDCA treatment.
Main Methods:
- 126 patients with PBC were analyzed for the association between URS-based probability of response (POR) and clinicopathological features.
- 30 patients underwent examination for the association between POR and pathological changes.
Main Results:
- The URS showed good predictive value for biochemical response (AUROC = 0.861).
- URS correlated significantly with Nakanuma staging and CK7 grading of liver histology.
- The score predicted histological stage progression after UDCA treatment.
Conclusions:
- The URS effectively predicts biochemical response to UDCA in PBC patients.
- The URS also reflects pre-treatment liver histology (Nakanuma system and CK7 grading).
- This scoring system helps identify inadequate histological response to UDCA therapy.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

